Ethnicity and outcome of young breast cancer patients in the United Kingdom: The POSH study

British Journal of Cancer

Volumn 110, Issue 1, 2014, Pages 230-241

  Copson, E ^a   Maishman, T ^a   Gerty, S ^a   Eccles, B ^a   Stanton, L ^a   Cutress, R I ^a   Altman, D G ^b   Durcan, L ^a   Simmonds, P ^a   Jones, L ^c   Tapper, W ^a   Eccles, Diana ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

breast cancer; ethnicity; prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR;

ARTICLE; ASIAN; BODY MASS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; COHORT ANALYSIS; DISTANT RELAPSE FREE SURVIVAL; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; ETHNIC GROUP; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NEGRO; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; TUMOR VOLUME; UNITED KINGDOM;

ADULT; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GREAT BRITAIN; HEALTH SERVICES ACCESSIBILITY; HUMANS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84891874192     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.650     Document Type: Article

References (46)

1. Abraham JE, Maranian MJ, Driver KE, Platte R, Kalmyrzaev B, Baynes C, Luccarini C, Shah M, Ingle S, Greenberg D, Earl HM, Dunning AM, Pharoah PD, Caldas C (2010) CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen. Breast Cancer Res 12: R64.
2. Ademuyiwa FO, Olopade OI (2003) Racial differences in genetic factors associated with breast cancer. Cancer Metastasis Rev 22: 47-53. (Pubitemid 36363513)
3. Agyemang C, Bhopal R, Bruijnzeels M (2005) Negro, Black, Black African, African Caribbean, African American or what? Labelling African origin populations in the health arena in the 21st century. J Epidemiol Commun Health 59: 1014-1018. (Pubitemid 41728262)
4. Albain KS, Unger JM, Crowley JJ, Coltman Jr CA, Hershman DL (2009) Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst 101: 984-992.
5. Antman K, Amato D, Wood W, Carson J, Suit H, Proppe K, Carey R, Greenberger J, Wilson R, Frei III E (1985) Selection bias in clinical trials. J Clin Oncol 3: 1142-1147. (Pubitemid 15004838)
6. Aspinall PJ (2011) The utility and validity for public health of ethnicity categorization in the 1991, 2001 and 2011 British Censuses. Public Health 125: 680-687.
7. Azim Jr HA, Santoro L, Russell-Edu W, Pentheroudakis G, Pavlidis N, Peccatori FA (2012) Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies. Cancer Treat Rev 38(7): 834-842.
8. Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl FF (1998) Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res 58: 65-70. (Pubitemid 28027718)
9. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triplenegative phenotype: a population-based study from the California cancer Registry. Cancer 109: 1721-1728. (Pubitemid 46668532)
10. Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, Mendez J, Guth AA (2006) Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol 24: 1357-1362. (Pubitemid 46621998)
11. Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL (2008) Early onset of breast cancer in a group of British black women. Br J Cancer 98: 277-281. (Pubitemid 351161260)
12. Bradford LD (2002) CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics 3: 229-243. (Pubitemid 34223859)
13. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295: 2492-2502. (Pubitemid 43854964)
14. Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 9: 439-448.
15. Coombs NJ, Boyages J (2005) Multi-focal and multi-centric breast cancer: Does each focus matter? J Clin Oncol 23: 7497-7502.
16. Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress RI, Altman DG, Durcan L, Simmonds P, Lawrence G, Jones L, Bliss J, Eccles D. POSH Study Steering Group (2013) Prospective Observational Study of Breast Cancer Treatment Outcomes for UK Women Aged 18-40 Years at Diagnosis: The POSH Study. J Natl Cancer Inst 105(13): 978-988.
17. Dignam JJ (2000) Differences in breast cancer prognosis among African American and Caucasian women. CA Cancer J Clin 50: 50-64. (Pubitemid 30072095)
18. Eccles D, Gerty S, Simmonds P, Hammond V, Ennis S, Altman DG (2007) Prospective study of Outcomes in Sporadic vs Hereditary breast cancer (POSH): study protocol. BMC Cancer 7: 160.
19. Elledge RM, Clark GM, Chamness GC, Osborne CK (1994) Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 86: 705-712. (Pubitemid 24138977)
20. El-Tamer MB, Wait RB (1999) Age at presentation of African-American and Caucasian breast cancer patients. J Am Coll Surg 188: 237-240. (Pubitemid 29113758)
21. Forbes LJ, Atkins L, Thurnham A (2011) Breast cancer awareness and barriers to symptomatic presentation among women from different ethnic groups in East London. Br J Cancer 105: 1474-1479.
22. Freedman RA, Yea VKH (2011) The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer 117: 180-189.
23. Gaedigk A, Bradford LD, Marcucci KA, Leeder JS (2002) Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans. Clin Pharmacol Ther 72: 76-89. (Pubitemid 34833189)
24. Gerend MA, Pai M (2008) Social determinants of Black-White disparities in breast cancer mortality: a review. Cancer Epidemiol Biomarkers Prev 17: 2913-2923.
25. Grann V, Troxel AB, Zojwalla N, Hershman D, Hershman D, Glied SA, Jacobson JS (2006) Regional and racial disparities in breast cancer-specific mortality. Soc Sci Med 62: 337-347. (Pubitemid 41735422)
26. Griggs JJ, Culakova E, Sorbero ME, Poniewierski MS, Wolff DA, Crawford, Dale DC, Lyman GH (2007a) Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens. J Clin Oncol 25(18): 2522-2527. (Pubitemid 47041224)
27. Griggs JJ, Culakova E, Sorbero ME, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH (2007b) Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. J Clin Oncol 25: 277-284. (Pubitemid 350010638)
28. Harding S, Rosato M (1999) Cancer incidence among first generation Scottish, Irish, West Indian and South Asian migrants living in England and Wales. Ethn Health 4: 83-92. (Pubitemid 29488199)
29. Hershman DL, Unger JM, Barlow WE, Hutchins LF, Martino S, Osborne CK, Livingston RB, Albain KS (2009) Treatment quality and outcomes of African American vs white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897. J Clin Oncol 27: 2157-2162.
30. Ingleby JD (2008) Early onset of breast cancer in Black British women: how reliable are the findings? Br J Cancer 99: 986-987.
31. Jack RH, Davies EA, Moller H (2009) Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England. Br J Cancer 100(3): 545-550.
32. Jatoi I, Becher H, Leake CR (2003) Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system. Cancer 98: 894-899. (Pubitemid 37022087)
33. Joslyn SA, West MM (2000) Racial differences in breast carcinoma survival. Cancer 88: 114-123. (Pubitemid 30027686)
34. Litton JK, Eralp Y, Gonzalez-Angulo A, Broglio K, Uyei A, Hortobagyi G, Arun B (2007) Multifocal breast cancer in women o35 years old. Cancer 110: 1445-1150.
35. Menashe I, Anderson WF, Jatoi I, Rosenberg PS (2009) Underlying causes of the black-white racial disparity in breast cancer mortality:a populationbased analysis. J Natl Cancer Inst 101: 993-1000.
36. McKenzie F, Jeffreys M (2009) Do lifestyle or social factors explain ethnic/racial inequalities in breast cancer. Epidemiol Rev 31: 52-66.
37. National Cancer Intelligence Network. Second all breast cancer report (2011) http://www.ncin.org.uk/publications/reports/default.aspx.
38. Newman LA, Alfonso AE (2007) Age-related differences in breast cancer stage at diagnosis between black and white patients in an urban community hospital. Ann Surg Oncol 4: 655-662.
39. Partridge AH, Wang PS, Winer EP, Avorn J (2003) Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 21: 602-606. (Pubitemid 46621892)
40. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
41. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, Thun M (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56: 168-183. (Pubitemid 43847927)
42. Taioli E, Trachman J, Chen X, Toniolo P, Garte SJ (1995) A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res 55: 3757-3758.
43. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D (2005) Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 294: 1765-1772. (Pubitemid 41434622)
44. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370: 1453-1457.
45. Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54: 78-93. (Pubitemid 38519418)
46. Wild SH, Fischbacher CM, Brock A, Griffiths C, Bhopal R (2006) Mortality from all cancers and lung, colorectal, breast and prostate cancer by country of birth in England and Wales, 2001-2003. Br J Cancer 94: 1079-1085.